Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Neurology ; 75(8): 693-8, 2010 Aug 24.
Article in English | MEDLINE | ID: mdl-20733144

ABSTRACT

OBJECTIVE: To identify and compare clinical and neuroimaging predictors of primary lobar intracerebral hemorrhage (ICH) recurrence, assessing their relative contributions to recurrent ICH. METHODS: Subjects were consecutive survivors of primary ICH drawn from a single-center prospective cohort study. Baseline clinical, imaging, and laboratory data were collected. Survivors were followed prospectively for recurrent ICH and intercurrent aspirin and warfarin use, including duration of exposure. Cox proportional hazards models were used to identify predictors of recurrence stratified by ICH location, with aspirin and warfarin exposures as time-dependent variables adjusting for potential confounders. RESULTS: A total of 104 primary lobar ICH survivors were enrolled. Recurrence of lobar ICH was associated with previous ICH before index event (hazard ratio [HR] 7.7, 95% confidence interval [CI] 1.4-15.7), number of lobar microbleeds (HR 2.93 with 2-4 microbleeds present, 95% CI 1.3-4.0; HR = 4.12 when >or=5 microbleeds present, 95% CI 1.6-9.3), and presence of CT-defined white matter hypodensity in the posterior region (HR 4.11, 95% CI 1.01-12.2). Although aspirin after ICH was not associated with lobar ICH recurrence in univariate analyses, in multivariate analyses adjusting for baseline clinical predictors, it independently increased the risk of ICH recurrence (HR 3.95, 95% CI 1.6-8.3, p = 0.021). CONCLUSIONS: Recurrence of lobar ICH is associated with previous microbleeds or macrobleeds and posterior CT white matter hypodensity, which may be markers of severity for underlying cerebral amyloid angiopathy. Use of an antiplatelet agent following lobar ICH may also increase recurrence risk.


Subject(s)
Aspirin/adverse effects , Cerebral Amyloid Angiopathy/drug therapy , Cerebral Amyloid Angiopathy/epidemiology , Cerebral Hemorrhage/chemically induced , Cerebral Hemorrhage/epidemiology , Platelet Aggregation Inhibitors/adverse effects , Aged , Aged, 80 and over , Anticoagulants/adverse effects , Cohort Studies , Female , Humans , Male , Middle Aged , Prospective Studies , Secondary Prevention , Warfarin/adverse effects
2.
Neurology ; 62(4): 654-6, 2004 Feb 24.
Article in English | MEDLINE | ID: mdl-14981191

ABSTRACT

Soluble Fas (sFas) and soluble Fas ligand (sFasL) are associated with cellular dysfunction and death and are elevated in CSF from patients with HIV dementia (HIV-D). The authors investigated whether these markers correlated with dementia severity and course. sFas and sFasL were measured in 15 highly active antiretroviral therapy (HAART)-naïve HIV-D subjects, 30 HAART-naïve HIV+ controls, and 17 HIV-controls. HIV-D subjects had higher CSF sFas levels than controls. Subjects with moderate/severe dementia had higher CSF sFas levels than those with mild dementia. CSF sFas trended lower in those with progressive dementia.


Subject(s)
AIDS Dementia Complex/cerebrospinal fluid , Membrane Glycoproteins/cerebrospinal fluid , fas Receptor/cerebrospinal fluid , AIDS Dementia Complex/pathology , Adult , Apoptosis , Astrocytes/pathology , Disease Progression , Fas Ligand Protein , Female , HIV Infections/cerebrospinal fluid , HIV Infections/psychology , Humans , Male , Middle Aged , Retrospective Studies , Severity of Illness Index , Solubility
SELECTION OF CITATIONS
SEARCH DETAIL
...